Ovarian Cancer
Aspirin inhibits tumor growth, USF lab study finds
Published in Cancer Weekly, December 17th, 2002
The study, published in Obstetrics and Gynecology, demonstrated that aspirin inhibited ovarian tumor cell growth by as much as 68%. The higher the dosage of aspirin added to the culture of ovarian cancer cells, the more growth inhibition was observed.
The researchers also found that combining aspirin with a monoclonal antibody specific for the HER-2/neu protein created even greater suppression of growth than treating the tumor cells with aspirin alone. This combination decreased ovarian cancer cell growth by 84%.
HER-2/neu is a receptor protein on the tumor...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2002-12-17)
More Articles from Cancer Weekly
- Cancer Vaccine
Carcinoembryonic antigen expressed by head and neck cancer tumors - Pancreatic Cancer
Gemcitabine and antibody combo knock out pancreatic tumors in mice - Bladder Cancer
Smoking and diabetes link seen postmenopausal women - Brain Cancer
Versatile immunosuppressant drug may have a new role in radiotherapy - Head and Neck Cancer
Combination of therapies halt squamous cell carcinoma - Lung Cancer
First potentially clinically useful independent marker identified - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
